Suppr超能文献

蛋白激酶 A 依赖性 β-连环蛋白 pSer(675),先天性肝纤维化小鼠模型中的一种新型信号缺陷。

Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis.

机构信息

Liver Center & Section of Digestive Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.

出版信息

Hepatology. 2013 Nov;58(5):1713-23. doi: 10.1002/hep.26554. Epub 2013 Sep 30.

Abstract

UNLABELLED

Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney disease (ARPKD). Cystic dysplasia of the intrahepatic bile ducts and progressive portal fibrosis characterize liver pathology in CHF/CD. At a cellular level, several functional morphological and signaling changes have been reported including increased levels of 3'-5'-cyclic adenosine monophosphate (cAMP). In this study we addressed the relationships between increased cAMP and β-catenin. In cholangiocytes isolated and cultured from Pkhd1(del4/del4) mice, stimulation of cAMP/PKA signaling (forskolin 10 μM) stimulated Ser(675) -phosphorylation of β-catenin, its nuclear localization, and its transcriptional activity (western blot and TOP flash assay, respectively) along with a down-regulation of E-cadherin expression (immunocytochemistry and western blot); these changes were inhibited by the PKA blocker, PKI (1 μM). The Rho-GTPase, Rac-1, was also significantly activated by cAMP in Pkhd1(del4/del4) cholangiocytes. Rac-1 inhibition blocked cAMP-dependent nuclear translocation and transcriptional activity of pSer(675) -β-catenin. Cell migration (Boyden chambers) was significantly higher in cholangiocytes obtained from Pkhd1(del4/del4) and was inhibited by: (1) PKI, (2) silencing β-catenin (siRNA), and (3) the Rac-1 inhibitor NSC 23766.

CONCLUSION

These data show that in fibrocystin-defective cholangiocytes, cAMP/PKA signaling stimulates pSer(675) -phosphorylation of β-catenin and Rac-1 activity. In the presence of activated Rac-1, pSer(675) -β-catenin is translocated to the nucleus, becomes transcriptionally active, and is responsible for increased motility of Pkhd1(del4/del4) cholangiocytes. β-Catenin-dependent changes in cell motility may be central to the pathogenesis of the disease and represent a potential therapeutic target.

摘要

未标记

纤维囊性蛋白功能的遗传缺失导致先天性肝纤维化(CHF)、Caroli 病(CD)和常染色体隐性多囊肾病(ARPKD)。CHF/CD 的肝病理学特征为肝内胆管囊性发育不良和进行性门脉纤维化。在细胞水平上,已经报道了几种功能形态和信号转导变化,包括 3'-5'-环腺苷酸(cAMP)水平升高。在这项研究中,我们研究了 cAMP 和β-连环蛋白之间的关系。在从 Pkhd1(del4/del4) 小鼠分离和培养的胆管细胞中,cAMP/PKA 信号刺激(forskolin 10 μM)刺激β-连环蛋白的 Ser(675)磷酸化、核定位及其转录活性(western blot 和 TOP flash 测定),同时下调 E-钙粘蛋白表达(免疫细胞化学和 western blot);这些变化被 PKA 阻断剂 PKI(1 μM)抑制。在 Pkhd1(del4/del4) 胆管细胞中,Rho-GTPase Rac-1 也被 cAMP 显著激活。Rac-1 抑制阻断了 cAMP 依赖性核转位和 pSer(675)-β-连环蛋白的转录活性。从 Pkhd1(del4/del4)获得的胆管细胞的细胞迁移(Boyden 室)明显更高,并受以下因素抑制:(1)PKI,(2)β-连环蛋白沉默(siRNA),和(3)Rac-1 抑制剂 NSC 23766。

结论

这些数据表明,在纤维囊性蛋白缺陷的胆管细胞中,cAMP/PKA 信号刺激 pSer(675)-β-连环蛋白磷酸化和 Rac-1 活性。在激活的 Rac-1 存在下,pSer(675)-β-连环蛋白易位到细胞核,转录活性增加,并负责增加 Pkhd1(del4/del4)胆管细胞的迁移能力。β-连环蛋白依赖性细胞迁移变化可能是疾病发病机制的核心,代表了潜在的治疗靶点。

相似文献

引用本文的文献

3
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.多囊肝疾病的遗传学、病理生物学和治疗机会。
Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):585-604. doi: 10.1038/s41575-022-00617-7. Epub 2022 May 13.

本文引用的文献

2
The complex world of WNT receptor signalling.WNT 受体信号转导的复杂世界。
Nat Rev Mol Cell Biol. 2012 Dec;13(12):767-79. doi: 10.1038/nrm3470. Epub 2012 Nov 15.
3
Fellow travellers: emergent properties of collective cell migration.同路人:集体细胞迁移的涌现特性。
EMBO Rep. 2012 Nov 6;13(11):984-91. doi: 10.1038/embor.2012.149. Epub 2012 Oct 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验